Untitled

Hillrom and WebWOC* present...”Disrupting the Vicious Cycle: Understanding & Preventing the Negative Effects of Moisture Before Incontinence Associated Dermatitis & Pressure Injury Occur”

This webinar will explore the latest research into the natural history of Incontinence Associated Dermatitis, including how the skin is damaged, and the time from exposure to irritants (in this case urine and fecal matter) to inflammation and skin damage. We will also discuss the latest interventions for early prevention of IAD and related pressure injury, and the effect of prompt and aggressive of urinary and fecal incontinence on patient satisfaction.

Learning Objectives  |  At the end of this session, participants should be able to:

• Review the latest findings related to the pathophysiology of skin when exposed to urine and stool and the effect of exposure time.
• Apply this knowledge to a structured management approach that prevent damage to the skin before IAD or pressure injury occur and improved patient satisfaction related to management of urinary and fecal incontinence.

Presenter:

Mikel Gray, PhD, FNP, PNP, CUNP, CCCN, FAANP, FAAN  |  Professor and Nurse Practioner  |  University of Virginia School of Nursing

Target Audience:  RN, Nurse Practioners, Health Care Professionals who work with WOC  patients

Continuing Education:  Nurses – ANCC and CBRN Accreditation Statements
The Wound, Ostomy and Continence Nurses Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.  The Wound, Ostomy and Continence Nurses Society is approved by the California Board of Registered Nursing, Provider Number CEP 15115.
Contact Hour(s): 1.00

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN or WOCN Society endorsement of any commercial product or service.

This webinar is supported by an educational grant from Hillrom. The WOCN® Society does not endorse specific products and services.

Questions should be directed to WebWOC:  877.796.1325

* NOTE: This is a supplier and industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.